Controlling the cost of personalized medicine: We go behind the scenes of the effort to build a system that simplifies production and reduces the cost of non-viral T cell therapies with Ziopharm Oncology CEO Laurence Cooper, M.D., Ph.D.
Not yet a member of BioProcess Online? Register today.
Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.
You might also want to: